Pacific Parkinson's Research Centre

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, Pacific Parkinson's Research Centre sits in the upper half of US sponsors by registered trial count (#7,388 of 15,742 sponsors by registered trial count).

1 total trials 1 currently recruiting upper half by trial count

Pacific Parkinson's Research Centre: 1 sponsored US clinical trial, 1 recruiting.

Pacific Parkinson's Research Centre sponsors 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting. The most-studied condition in this pipeline is GBA Gene Mutation, with 1 trials.

Mid-pack sponsor footprint

Pacific Parkinson's Research Centre is in the upper half of sponsors by trial count (#7,388 of 15,742 sponsors by registered trial count). Use the pipeline list and therapeutic areas to see what drives that mid-pack volume.

What is open in the Pacific Parkinson's Research Centre pipeline

1 recruiting of 1 indexed (100% open).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: GBA Gene Mutation (1 trial), 2 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Pacific Parkinson's Research Centre: open-pipeline peers nationwide

Peers matched on 1 registered trials and 100% open enrollment, not the therapeutic-area sidebar.

Pacific Parkinson's Research Centre sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 012345 0%50%100%150% Total trials Recruiting share Pacific Parkinson's Research Centre1200 Pharma1ST Biotherapeutics3 Waves Wellness3EO HealthAAVantgarde Bio SrlAcorn BiolabsAcrivon TherapeuticsADARx Pharmaceuticals
Pacific Parkinson's Research Centre sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Pacific Parkinson's Research Centre sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 1 trials (± recruiting share)

Sponsors near 100% open enrollment (± trial volume)

What to do with this Pacific Parkinson's Research Centre page

1 registered trials is a research-attention snapshot, not an endorsement of Pacific Parkinson's Research Centre or any single study.

  • 1 of Pacific Parkinson's Research Centre's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • GBA Gene Mutation is the condition Pacific Parkinson's Research Centre studies most, compare against other sponsors active in the same condition before evaluating a specific study. See GBA Gene Mutation trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Pacific Parkinson's Research Centre pipeline card: 1 registered trials from official public datasets.Report a data error.